Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

summit company (malaysia) sendirian berhad - benzalkonium chloride; cetrimide; zinc oxide -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

summit company (malaysia) sendirian berhad - cetrimide; zinc oxide; benzalkonium chloride 80% -

India - English - Central Drugs Standard Control Organization

intas - etoricoxib - tab - 120mg - 10

India - English - Central Drugs Standard Control Organization

intas - etoricoxib - tab - 60/90;mg - 10

Israel - English - Ministry of Health

novartis israel ltd - nilotinib as monohydrate - capsules - nilotinib as monohydrate 200 mg - nilotinib - nilotinib - treatment of philadelphia chromosome positive chronic myeloid leukaemia (ph+ cml) in chronic or accelerated phase in patients resistant to or experiencing significant toxicity during treatment with imatinib.treatment of adult patients with newly diagnosed philadelphia chromosome positive chronic myelogenous leukemia in chronic phase.

Israel - English - Ministry of Health

novartis israel ltd - nilotinib as hydrochloride monohydrate - capsules - nilotinib as hydrochloride monohydrate 150 mg - nilotinib - nilotinib - treatment of adult patients with newly diagnosed philadelphia chromosome positive chronic myelogenous leukemia in chronic phase.

European Union - English - EMA (European Medicines Agency)

allergan pharmaceuticals international ltd - pancreas powder - exocrine pancreatic insufficiency - digestives, incl. enzymes - pancreatic enzyme replacement treatment in exocrine pancreatic insufficiency due to cystic fibrosis or other conditions (e.g. chronic pancreatitis, post pancreatectomy or pancreatic cancer).enzepi is indicated in infants, children, adolescents and adults.

European Union - English - EMA (European Medicines Agency)

retrophin europe ltd - cholic acid - metabolism, inborn errors - bile and liver therapy - cholic acid fgk is indicated for the treatment of inborn errors of primary bile acid synthesis, in infants from one month of age for continuous lifelong treatment through adulthood, encompassing the following single enzyme defects:sterol 27-hydroxylase (presenting as cerebrotendinous xanthomatosis, ctx) deficiency;2- (or alpha-) methylacyl-coa racemase (amacr) deficiency;cholesterol 7 alpha-hydroxylase (cyp7a1) deficiency.

Canada - English - Health Canada

herdt et charton inc. - octinoxate; octocrylene; titanium dioxide; oxybenzone - lotion - 7.5%; 5%; 2%; 2% - octinoxate 7.5%; octocrylene 5%; titanium dioxide 2%; oxybenzone 2% - sunscreen agents

Canada - English - Health Canada

herdt et charton inc. - octinoxate; octocrylene; titanium dioxide - lotion - 7.5%; 4%; 2% - octinoxate 7.5%; octocrylene 4%; titanium dioxide 2% - sunscreen agents